Latest Guidance on Masks from the CDC

Environmental & Science Education, STEM, Health, Medicine

Ed Hessler 

The Centers for Disease Control (CDC) has just released the following recommendations which apply to non-healthcare settings.

Fully vaccinated people can:

• Visit with other fully vaccinated people indoors without wearing masks or physical distancing
• Visit with unvaccinated people (including children) from a single household who are at low risk for severe COVID-19 disease indoors without wearing masks or physical distancing
• Participate in outdoor activities and recreation without a mask, except in certain crowded settings and venues
• Resume domestic travel and refrain from testing before or after travel or self-quarantine after travel.
• Refrain from testing before leaving the United States for international travel (unless required by the destination) and refrain from self-quarantine after arriving back in the United States.
• Refrain from testing following a known exposure, if asymptomatic, with some exceptions for specific settings
• Refrain from quarantine following a known exposure if asymptomatic
• Refrain from routine screening testing if asymptomatic and feasible

For now, fully vaccinated people should continue to:

• Take precautions in indoor public settings like wearing a well-fitted mask
• Wear masks that fit snuggly when visiting indoors with unvaccinated people who are at increased risk for severe COVID-19 disease or who have an unvaccinated household member who is at increased risk for severe COVID-19 disease
• Wear well-fitted masks when visiting indoors with unvaccinated people from multiple households
• Avoid indoor large-sized in-person gatherings
• Get tested if experiencing COVID-19 symptoms
• Follow guidance issued by individual employers
• Follow CDC and health department travel requirements and recommendations

The latest guidance may be read here. 

This update is dated April 27, 2021.

For the purposes of this guidance, people are considered fully vaccinated for COVID-19 ≥2 weeks after they have received the second dose in a 2-dose series (Pfizer-BioNTech or Moderna), or ≥2 weeks after they have received a single-dose vaccine (Johnson and Johnson (J&J)/Janssen).

 

 

•  
•